Combined synopsis and solicitation
Provision of Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies
75F40126Q00204
Food and Drug Administration, Food and Drug Administration. All Other Animal Production.
Response deadline
July 10, 2026 at 2:00 PM EDT
Closed 114 days ago. Posted June 29, 2026, first published June 25, 2026. Scheduled to archive July 25, 2026.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 2026
5 like it are open now in all other animal production
- Border Patrol Untrained Canine – Detection BPK9 – El Paso, TX.
US Customs and Border Protection, Mission Support Contracting Division
Combined synopsis and solicitationSmall businessNAICS 112990Anywhere in the US20161894Closes in 3 daysNov 4 - Border Patrol Untrained Canine – Detection BPK9 – El Paso, TX.
US Customs and Border Protection, Mission Support Contracting Division
Combined synopsis and solicitationSmall businessNAICS 112990Anywhere in the US20151893Closes in 3 daysNov 4 - Border Patrol Request for Quote (RFQ) for Patrol (Dual Purpose) Canines
US Customs and Border Protection, Mission Support Contracting Division
Combined synopsis and solicitationSmall businessNAICS 112990Anywhere in the US20161895Closes in 3 daysNov 4
Description
As published on SAM.gov.
6/29/2026; See attached amendment 1 to the combined synopsis/solicitation.
Pertussis is an acute, highly contagious, potentially life-threatening respiratory disease, caused by the Gram-negative bacterium Bordetella pertussis. The underlying factors leading to the failure of public health measures to control pertussis disease using currently licensed vaccines are poorly understood. A more complete understanding of this disease and of the mechanisms of vaccine-mediated protection is a critical public health need.
The baboon model of pertussis, developed in the laboratories of the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), is the only animal model of pertussis that recapitulates the disease as observed in human patients. Refinement of the baboon model to include establishment of infection by means of natural transmission will enable a more refine evaluation of the differences between the licensed acellular pertussis vaccines that fail to prevent infection and the whole cell vaccines that reduce infection. The performance of this study requires the purchase and delivery of twenty, Bordetella-free baboons.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- Sol Doc 134085.pdf288 KB, June 25, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
June 25, 2026
Combined synopsis and solicitation, originally sources sought
Due July 10, 2026 at 2:00 PM EDT. SAM.gov, notice fa39d7200d044035b21a363f765ea651
3 revisions on SAM
- June 29, 2026: publish, combined synopsis and solicitation
- June 25, 2026: publish, combined synopsis and solicitation
- May 21, 2026: publish, sources sought
June 29, 2026
Combined synopsis and solicitation
Due July 10, 2026 at 2:00 PM EDT. SAM.gov, notice a3a0d837a54747d39a3893ac8c767908
3 revisions on SAM
- June 29, 2026: publish, combined synopsis and solicitation
- June 25, 2026: publish, combined synopsis and solicitation
- May 21, 2026: publish, sources sought
Points of contact
- David Kramerdavid.kramer@fda.hhs.gov
- Nick Sartainnick.sartain@fda.hhs.gov